AI can accelerate study-build foundations, but only when teams combine targeted automation with standards, traceability and control.
In 2026, clinical trial teams must be prepared to navigate market uncertainty and identify high-impact areas for AI adoption to…
AI can accelerate study-build foundations, but only when teams combine targeted automation with standards, traceability and control.
In 2026, clinical trial teams must be prepared to navigate market uncertainty and identify high-impact areas for AI adoption to…
Support services are fundamentally important to CDMS vendor selection. Consider the story of this complex rescue study when evaluating an…
As clinical trials become more complex, the ICH E6 (R3) updates emphasize smarter monitoring, greater participant focus, and a stronger…
As the complexities of clinical trial data management ramp up, traditional outsourcing models are changing.
Platform trials offer increased flexibility and reduced costs for sponsors and CROs in clinical studies. Digital EDC solutions ensure that…
The financial challenges facing clinical trials have created a more risk-averse landscape. Yet digital solutions could be the key for…
A successful clinical trial requires an effective randomization strategy formulated by innovative thinking to meet unique demands. In a recent…
With the boom in eClinical solutions showing no signs of slowing, adding a “human at the center” perspective can help…
Large language models (LLMs) such as ChatGPT are frequently hailed as revolutionary tools for any workplace. However, in the pharma…
Customize your clinical trial development with the capabilities you need to get your treatment to market faster with Zelta™.
Read More